rs777094000
Positions:
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_ModeratePP5_Moderate
The NM_002929.3(GRK1):c.1139T>A(p.Val380Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000436 in 1,536,438 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Genomes: 𝑓 0.000040 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000044 ( 0 hom. )
Consequence
GRK1
NM_002929.3 missense
NM_002929.3 missense
Scores
5
11
2
Clinical Significance
Conservation
PhyloP100: 2.00
Genes affected
GRK1 (HGNC:10013): (G protein-coupled receptor kinase 1) This gene encodes a member of the guanine nucleotide-binding protein (G protein)-coupled receptor kinase subfamily of the Ser/Thr protein kinase family. The protein phosphorylates rhodopsin and initiates its deactivation. Defects in GRK1 are known to cause Oguchi disease 2 (also known as stationary night blindness Oguchi type-2). [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.899
PP5
Variant 13-113731288-T-A is Pathogenic according to our data. Variant chr13-113731288-T-A is described in ClinVar as [Pathogenic]. Clinvar id is 13010.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr13-113731288-T-A is described in UniProt as null. Variant chr13-113731288-T-A is described in Lovd as [Likely_pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GRK1 | NM_002929.3 | c.1139T>A | p.Val380Asp | missense_variant | 5/7 | ENST00000335678.7 | NP_002920.1 | |
GRK1 | XM_047430493.1 | c.434T>A | p.Val145Asp | missense_variant | 5/7 | XP_047286449.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GRK1 | ENST00000335678.7 | c.1139T>A | p.Val380Asp | missense_variant | 5/7 | 1 | NM_002929.3 | ENSP00000334876 | P1 | |
GRK1 | ENST00000545304.1 | n.122T>A | non_coding_transcript_exon_variant | 2/4 | 4 |
Frequencies
GnomAD3 genomes AF: 0.0000396 AC: 6AN: 151634Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
6
AN:
151634
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000282 AC: 4AN: 141852Hom.: 0 AF XY: 0.0000264 AC XY: 2AN XY: 75852
GnomAD3 exomes
AF:
AC:
4
AN:
141852
Hom.:
AF XY:
AC XY:
2
AN XY:
75852
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000440 AC: 61AN: 1384804Hom.: 0 Cov.: 31 AF XY: 0.0000395 AC XY: 27AN XY: 683328
GnomAD4 exome
AF:
AC:
61
AN:
1384804
Hom.:
Cov.:
31
AF XY:
AC XY:
27
AN XY:
683328
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000396 AC: 6AN: 151634Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74016
GnomAD4 genome
AF:
AC:
6
AN:
151634
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
74016
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
1
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Oguchi disease-2 Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Feb 01, 1997 | - - |
Likely pathogenic, no assertion criteria provided | research | Molecular Medicine, University of Leeds | Feb 20, 2019 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Oct 19, 2022 | Published functional studies demonstrate reduced enzymatic activity and decreased protein expression (Khani et al., 1998); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 31589614, 17070587, 22959359, 33252155, 9020843, 9501174) - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D
MetaSVM
Benign
T
MutationTaster
Benign
D
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D
REVEL
Uncertain
Sift
Uncertain
D
Sift4G
Pathogenic
D
Polyphen
D
Vest4
MutPred
Gain of catalytic residue at F376 (P = 0.0415);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at